News | July 27, 2008

New Family of Neurovascular Retrievers Launched by Concentric Medical

July 28, 2008 - Concentric Medical Inc. today said it launched its “V” series of Merci Retrievers, available in multiple configurations and sizes to match patient anatomy to remove blood clots and help restore blood flow in patients who have suffered ischemic strokes.

The distal end of the latest Retriever is tightly coiled, which resists stretching and assists in dislodging clots. The proximal end of the V series retrievers is more loosely coiled, which facilitates wrapping and holding a dislodged clot. Similar to Concentric Medical’s L family of retrievers, the V series of Merci Retrievers incorporate filaments that provide an additional mechanism for securing blood clots during retrieval from the brain, the company said. The V series of Merci Retrievers will be available in diameters of 2.0, 2.5 and 3.0 millimeters.

The Merci Retriever is made with a flexible, shaped Nitinol wire that allows delivery of the retriever in linear form using standard catheterization techniques. A neurointerventionalist makes a small puncture in the groin to introduce the Merci Retriever into an artery leading to the brain. The Merci Retriever returns to its original shape when deployed in and around the blood clot in the brain.

For more information: www.concentric-medical.com


Related Content

News | Stroke

May 28, 2025 — Siemens Healthineers has introduced the first mobile stroke unit (MSU) featuring the Somatom On.site head ...

Home May 28, 2025
Home
News | Stroke

May 21, 2025 — RapidAI recently announced new study findings that show RapidAI’s clinically deep algorithms deliver ...

Home May 21, 2025
Home
News | Stroke

April 17, 2025 — Adults younger than 50 years of age had more than double the risk of having a stroke from migraine or ...

Home April 17, 2025
Home
News | Stroke

On April 9, 2025, the world’s first multisector advocacy movement dedicated to stroke — the Global Stroke Action ...

Home April 15, 2025
Home
News | Stroke

March 3, 2025 — Genentech, a member of the Roche Group, recently announced that the U.S. Food and Drug Administration ...

Home March 04, 2025
Home
News | Stroke

Feb. 6, 2025 — New findings from the DiVERT Stroke clinical study showed women spent less time in the hospital, saw ...

Home February 07, 2025
Home
News | Stroke

Feb. 5, 2025 — Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment ...

Home February 07, 2025
Home
News | Stroke

Jan. 29, 2025 — Researchers at Ochsner Health, led by Hernan Bazan, MD, DFSVS, FACS, have developed a predictive model ...

Home January 30, 2025
Home
News | Stroke

Nov. 16, 2024 Anthos Therapeutics, Inc.recently presented new data at the American Heart Association (AHA) Scientific ...

Home November 18, 2024
Home
News | Stroke

Oct. 24, 2024 – Royal Philips and Medtronic Neurovascular have announced a strategic advocacy partnership. Delivering ...

Home October 24, 2024
Home
Subscribe Now